REQUEST A DEMO
Total
USD $0.00
Search more companies

Heilongjiang Zbd Pharmaceutical Co.,Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Heilongjiang Zbd Pharmaceutical Co.,Ltd. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Heilongjiang Zbd Pharmaceutical Co., Ltd. is a modern pharmaceutical company located in Harbin, China. The company specializes in the production, sales, and research and development of high-end traditional Chinese medicine formulations. They prioritize the inheritance and innovation of traditional Chinese medicine culture throughout the entire process of drug production and quality management. The company has established a technology innovation platform that involves collaboration with universities and research institutions, actively conducting research on the basic theories of traditional Chinese medicine and cutting-edge scientific and technological advancements both domestically and internationally. Through collaboration with universities and research institutions, they have achieved automated online monitoring during the extraction process of traditional Chinese medicine and automated quality control throughout the entire drug formulation production process. They also utilize advanced monitoring technologies such as traditional Chinese medicine fingerprinting system to ensure the safety, reliability, uniformity, effectiveness, and controllability of drug quality. The company implements a comprehensive risk management mechanism from production to the end market, ensuring that the entire process is controllable and reliable for public medication. To accelerate the perfect integration of traditional medicine and modern science and technology, the company has established a complete pharmaceutical industry chain, including variety research and development, cultivation of traditional Chinese medicinal materials, extraction, formulation production, drug testing, and sales distribution.

Headquarters
No. 8, Yantai 1st Road, Pingfang District, Harbin City, Heilongjiang Province
Harbin; Heilongjiang; Postal Code: 150060

Contact Details: Purchase the Heilongjiang Zbd Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.zbdzy.com

Basic Information
Total Employees:
Purchase the Heilongjiang Zbd Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Heilongjiang Zbd Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Heilongjiang Zbd Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Heilongjiang Zbd Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
October 28, 1996
Key Executives
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
51.27%
Purchase this report to view the information.
9.36%
Purchase this report to view the information.
8.96%
Purchase this report to view the information.
5%
Purchase this report to view the information.
2.39%
Subsidiaries
Beijing Hengchuang Xingyuan Pharmaceutical Technology Co., Ltd.
100%
Beijing Zhenbaodao Pharmaceutical Commercial Management Co., Ltd.
100%
Bozhou Traditional Chinese Medicine Commodity Trading Center Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Heilongjiang Zbd Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-40.94%
Total operating revenue
-43.06%
Operating profit (EBIT)
-24.61%
Net Profit (Loss) for the Period
-16.8%
Total assets
8.7%
Total equity
9.16%
Operating Profit Margin (ROS)
4.69%
Net Profit Margin
5.66%
Return on Equity (ROE)
-1.5%
Debt to Equity Ratio
2.26%
Quick Ratio
0.18%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?